Antibiotics for community-acquired pneumonia in adults [4]

New England Journal of Medicine

Volumn 373, Issue 7, 2015, Pages 684-

  Nie, Wei ^a   Li, Bing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; ANTIINFECTIVE AGENT; BETA LACTAM; QUINOLONE DERIVATIVE;

ADULT; CLINICAL TRIAL (TOPIC); COMBINATION CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; CORRELATIONAL STUDY; CURB 65; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; LETTER; META ANALYSIS (TOPIC); MONOTHERAPY; MORTALITY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); FEMALE; MALE; PNEUMONIA, BACTERIAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; FEMALE; FLUOROQUINOLONES; HUMANS; MACROLIDES; MALE; PNEUMONIA, BACTERIAL;

EID: 84941615609     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1506892     Document Type: Letter

References (2)

1. Garin N, Genné D, Carballo S, et al. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med 2014;174:1894-901.
2. Nie W, Li B, Xiu Q. β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. J Antimicrob Chemother 2014;69:1441-6.